门静脉栓塞预处理调节肝血流动力学并改善扩大肝切除猪的肝功能
该研究在猪90%扩大肝切除模型中,评估术前24小时门静脉栓塞预处理对肝血流动力学和肝功能的影响。结果显示预处理组门静脉压力升高显著减轻,肝动脉血流、肝功能及门管区水肿均改善,且不依赖肝细胞增殖,可能与Klf2基因诱导相关。提示门静脉栓塞预处理或为扩大肝切除的保肝策略。
要点
- 术前24小时门静脉栓塞可减轻扩大肝切除后门静脉高压。
- 预处理改善肝动脉血流、肝功能及门管区水肿。
- 保护效应不依赖肝细胞增殖或肝脏生长。
核心结论
- 门静脉栓塞预处理是扩大肝切除的潜在保肝策略。
- 肝血流动力学可能是肝切除后肝衰竭的主要致病因素。
研究设计与样本
- 猪扩大(90%)肝切除模型,门静脉栓塞组与对照组各10只,门静脉栓塞在术前24小时实施。
- 评估血检、肝与全身血流动力学、肝功能(吲哚菁绿血浆消失率)、肝组织学及CT容积。
- 检测肝细胞增殖细胞核抗原表达及肝脏基因表达。
主要发现
- 对照组与门静脉栓塞组全身血流动力学稳定,门静脉血流增加相似(302±72% vs 486±92%,P=.13)。
- 对照组门静脉压力从9.4±1.3 mmHg升至20.9±1.4 mmHg(P<.001),门静脉栓塞组从11.4±1.5 mmHg升至16.1±1.3 mmHg(P=.061)。
- 门静脉栓塞改善肝动脉血流保存、肝功能及门管区水肿。
- 上述效应不伴肝细胞增殖或肝脏生长,与血管保护基因Klf2诱导相关。
临床怎么用
- 扩大肝切除前24小时行门静脉栓塞可能减轻术后门静脉高压并保护肝功能。
- 需进一步临床前研究评估其中期效应包括生存率。
局限性
- 仅为猪临床前研究,样本量每组10只。
- 未评估中期效应及生存率。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Portal vein embolization is performed weeks before extended hepatic resections to increase the future liver remnant and prevent posthepatectomy liver failure. Portal vein embolization performed closer to the operation also could be protective, but worsening of portal hyper-perfusion is a major concern. We determined the hepatic hemodynamic effects of a portal vein embolization performed 24 hours prior to hepatic operation. METHODS: An extended (90%) hepatectomy was performed in swine undergoing (portal vein embolization) or not undergoing (control) a portal vein embolization 24 hours earlier (n = 10/group). Blood tests, hepatic and systemic hemodynamics, hepatic function (plasma disappearance rate of indocyanine green), liver histology, and volumetry (computed tomographic scanning) were assessed before and after the hepatectomy. Hepatocyte proliferating cell nuclear antigen expression and hepatic gene expression also were evaluated. RESULTS: Swine in the control and portal vein embolization groups maintained stable systemic hemodynamics and developed similar increases of portal blood flow (302 ± 72% vs 486 ± 92%, P = .13). Portal pressure drastically increased in Controls (from 9.4 ± 1.3 mm Hg to 20.9 ± 1.4 mm Hg, P < .001), while being markedly attenuated in the portal vein embolization group (from 11.4 ± 1.5 mm Hg to 16.1 ± 1.3 mm Hg, P = .061). The procedure also improved the preservation of the hepatic artery blood flow, liver function, and periportal edema. These effects occurred in the absence of hepatocyte proliferation or hepatic growth and were associated with the induction of the vasoprotective gene Klf2. CONCLUSION: Portal vein embolization preconditioning represents a potential hepato-protective strategy for extended hepatic resections. Further preclinical studies should assess its medium-term effects, including survival. Our study also supports the relevance of hepatic hemodynamics as the main pathogenetic factor of post-hepatectomy liver failure.
引用
- Asencio JM, García-Sabrido JL, López-Baena JA, et al. Preconditioning by portal vein embolization modulates hepatic hemodynamics and improves liver function in pigs with extended hepatectomy. Surgery. 2017. PMID: 28117095. doi:10.1016/j.surg.2016.12.003
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。